Literature DB >> 23083784

A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011.

Gregory J Dehmer1, Douglas Weaver, Matthew T Roe, Sarah Milford-Beland, Susan Fitzgerald, Anthony Hermann, John Messenger, Issam Moussa, Kirk Garratt, John Rumsfeld, Ralph G Brindis.   

Abstract

OBJECTIVES: This study sought to provide a report to the public of data from the CathPCI Registry of the National Cardiovascular Data Registry.
BACKGROUND: The CathPCI Registry collects data from approximately 85% of the cardiac catheterization laboratories in the United States.
METHODS: Data were summarized for 6 consecutive calendar quarters beginning January 1, 2010, and ending June 30, 2011. This report includes 1,110,150 patients undergoing only diagnostic cardiac catheterization and 941,248 undergoing percutaneous coronary intervention (PCI).
RESULTS: Some notable findings include, for example, that on-site cardiac surgery was not available in 83% of facilities performing fewer than 200 PCIs annually, with these facilities representing 32.6% of the facilities reporting, but performing only 12.4% of the PCIs in this data sample. Patients 65 years of age or older represented 38.7% of those undergoing PCI, with 12.3% being 80 years of age or older. Almost 80% of PCI patients were overweight (body mass index ≥25 kg/m(2)), 80% had dyslipidemia, and 27.6% were current or recent smokers. Among patients undergoing elective PCI, 52% underwent a stress study before the procedure, with stress myocardial perfusion being used most frequently. Calcium scores and coronary computed tomography angiography were used very infrequently (<3%) before diagnostic or PCI procedures. Radial artery access was used in 8.3% of diagnostic and 6.9% of PCI procedures. Primary PCI was performed with a median door-to-balloon time of 64.5 min for nontransfer patients and 121 min for transfer patients. In-hospital risk-adjusted mortality in ST-segment elevation myocardial infarction patients was 5.2% in this sample.
CONCLUSIONS: Data from the CathPCI Registry provide a contemporary view of the current practice of invasive cardiology in the United States.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23083784     DOI: 10.1016/j.jacc.2012.08.966

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  70 in total

1.  In-Hospital and One-Year Clinical Outcome of Percutaneous Coronary Intervention in a Tertiary Hospital in Oman: Oman PCI Registry.

Authors:  Prashanth Panduranga; Majdah Al-Rashidi; Fatma Al-Hajri
Journal:  Oman Med J       Date:  2017-01

2.  Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents.

Authors:  Pallav Garg; Benjamin Z Galper; David J Cohen; Robert W Yeh; Laura Mauri
Journal:  Am Heart J       Date:  2014-11-10       Impact factor: 4.749

3.  Sex Differences in Outcomes Following Percutaneous Coronary Intervention According to Age.

Authors:  Kelly C Epps; Elizabeth M Holper; Faith Selzer; Helen A Vlachos; Sarah K Gualano; J Dawn Abbott; Alice K Jacobs; Oscar C Marroquin; Srihari S Naidu; Peter W Groeneveld; Robert L Wilensky
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-02

Review 4.  Achieving safe femoral arterial access.

Authors:  Michael S Lee; Jeremy Kong
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

5.  Follow-up tests and outcomes for patients undergoing percutaneous coronary intervention: analysis of a Japanese administrative database.

Authors:  Tomotsugu Seki; Masato Takeuchi; Ryusuke Miki; Koji Kawakami
Journal:  Heart Vessels       Date:  2018-07-14       Impact factor: 2.037

6.  Interventional cardiology. PCI without surgical backup--evidence-based, but wise?

Authors:  Thomas M Maddox; John S Rumsfeld
Journal:  Nat Rev Cardiol       Date:  2013-05-07       Impact factor: 32.419

Review 7.  Integrin αIIbβ3: from discovery to efficacious therapeutic target.

Authors:  Kamila Bledzka; Susan S Smyth; Edward F Plow
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367

Review 8.  Application of appropriate use criteria for percutaneous coronary intervention in Japan.

Authors:  Taku Inohara; Shun Kohsaka; Ikuko Ueda; Takashi Yagi; Yohei Numasawa; Masahiro Suzuki; Yuichiro Maekawa; Keiichi Fukuda
Journal:  World J Cardiol       Date:  2016-08-26

9.  Predicting target vessel revascularization in older patients undergoing percutaneous coronary intervention in the drug-eluting stent era.

Authors:  Connie N Hess; Sunil V Rao; David Dai; Megan L Neely; Robert N Piana; John C Messenger; Eric D Peterson
Journal:  Am Heart J       Date:  2014-01-04       Impact factor: 4.749

10.  Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI Study.

Authors:  Xin Zheng; Jeptha P Curtis; Shuang Hu; Yongfei Wang; Yuejin Yang; Frederick A Masoudi; John A Spertus; Xi Li; Jing Li; Kumar Dharmarajan; Nicholas S Downing; Harlan M Krumholz; Lixin Jiang
Journal:  JAMA Intern Med       Date:  2016-04       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.